PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Adicet Bio, Inc. (ACET)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0070021086
CUSIP007002108
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$179.92M
EPS-$3.31
PEG Ratio0.82
Gross Profit (TTM)$24.99M
EBITDA (TTM)-$126.48M
Year Range$1.10 - $7.50
Target Price$9.00
Short %7.99%
Short Ratio2.96

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACET

Adicet Bio, Inc.

Popular comparisons: ACET vs. YRD, ACET vs. ETON

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Adicet Bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%OctoberNovemberDecember2024FebruaryMarch
-98.01%
82.90%
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Adicet Bio, Inc. had a return of 24.34% year-to-date (YTD) and -61.16% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date24.34%10.16%
1 month-1.67%3.47%
6 months65.49%22.20%
1 year-61.16%30.45%
5 years (annualized)-45.30%13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202458.20%-21.40%
2023-25.09%-31.50%-3.65%-10.61%60.17%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Adicet Bio, Inc. (ACET) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACET
Adicet Bio, Inc.
-0.51
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Adicet Bio, Inc. Sharpe ratio is -0.51. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.51
2.79
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Adicet Bio, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-98.39%
0
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adicet Bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adicet Bio, Inc. was 99.24%, occurring on Nov 28, 2023. The portfolio has not yet recovered.

The current Adicet Bio, Inc. drawdown is 98.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.24%Feb 26, 20181450Nov 28, 2023
-6.75%Jan 29, 20182Jan 30, 20183Feb 2, 20185
-5.63%Feb 5, 20182Feb 6, 20184Feb 12, 20186
-0.88%Feb 14, 20181Feb 14, 20182Feb 16, 20183
-0.2%Feb 22, 20181Feb 22, 20181Feb 23, 20182

Volatility

Volatility Chart

The current Adicet Bio, Inc. volatility is 17.88%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%OctoberNovemberDecember2024FebruaryMarch
17.88%
2.80%
ACET (Adicet Bio, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Adicet Bio, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items